DK0494294T3 - Bakterielle stressproteiner - Google Patents

Bakterielle stressproteiner

Info

Publication number
DK0494294T3
DK0494294T3 DK91914019.4T DK91914019T DK0494294T3 DK 0494294 T3 DK0494294 T3 DK 0494294T3 DK 91914019 T DK91914019 T DK 91914019T DK 0494294 T3 DK0494294 T3 DK 0494294T3
Authority
DK
Denmark
Prior art keywords
corynebacterium
stress protein
protein
peptide
stress proteins
Prior art date
Application number
DK91914019.4T
Other languages
English (en)
Inventor
James Peter Burnie
Original Assignee
Univ Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Manchester filed Critical Univ Manchester
Application granted granted Critical
Publication of DK0494294T3 publication Critical patent/DK0494294T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1285—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Corynebacterium (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK91914019.4T 1990-07-25 1991-07-25 Bakterielle stressproteiner DK0494294T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909016315A GB9016315D0 (en) 1990-07-25 1990-07-25 Medicaments

Publications (1)

Publication Number Publication Date
DK0494294T3 true DK0494294T3 (da) 1994-11-14

Family

ID=10679630

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91914019.4T DK0494294T3 (da) 1990-07-25 1991-07-25 Bakterielle stressproteiner

Country Status (9)

Country Link
US (2) US6040148A (da)
EP (1) EP0494294B1 (da)
JP (1) JP3747057B2 (da)
AT (1) ATE112783T1 (da)
DE (1) DE69104602T2 (da)
DK (1) DK0494294T3 (da)
ES (1) ES2062809T3 (da)
GB (1) GB9016315D0 (da)
WO (1) WO1992001717A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2270076A (en) * 1992-08-18 1994-03-02 Univ Manchester Human HSP 90 Epitopes
US5750119A (en) 1994-01-13 1998-05-12 Mount Sinai School Of Medicine Of The City University Of New York Immunotherapeutic stress protein-peptide complexes against cancer
US5997873A (en) 1994-01-13 1999-12-07 Mount Sinai School Of Medicine Of The City University Of New York Method of preparation of heat shock protein 70-peptide complexes
US5961979A (en) 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
US5935576A (en) * 1995-09-13 1999-08-10 Fordham University Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
US5985270A (en) * 1995-09-13 1999-11-16 Fordham University Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
US5837251A (en) 1995-09-13 1998-11-17 Fordham University Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
US5830464A (en) * 1997-02-07 1998-11-03 Fordham University Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
US6017540A (en) 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
US5948646A (en) 1997-12-11 1999-09-07 Fordham University Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
ATE482714T1 (de) 1998-02-20 2010-10-15 Univ Miami Modifizierter hitzeschockprotein-antigenpeptid- komplex
AU6669401A (en) 2000-06-02 2001-12-11 Univ Connecticut Health Ct Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
WO2003015712A2 (en) 2001-08-20 2003-02-27 University Of Connecticut Health Center Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin
CN102014937A (zh) 2008-03-03 2011-04-13 迈阿密大学 基于异基因癌细胞的免疫治疗
EP2274001A4 (en) 2008-03-20 2012-08-01 Univ Miami GP96 THERMAL IMPACT PROTEIN VACCINATION AND METHODS OF USE
WO2016127015A1 (en) 2015-02-06 2016-08-11 Heat Biologics, Inc. Vector co-expressing vaccine and costimulatory molecules
WO2018071405A1 (en) 2016-10-11 2018-04-19 University Of Miami Vectors and vaccine cells for immunity against zika virus
US11548930B2 (en) 2017-04-04 2023-01-10 Heat Biologics, Inc. Intratumoral vaccination

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
GB8915019D0 (en) * 1989-06-30 1989-08-23 Matthews Ruth C Medicaments

Also Published As

Publication number Publication date
JPH05503943A (ja) 1993-06-24
JP3747057B2 (ja) 2006-02-22
DE69104602T2 (de) 1995-05-11
US5985277A (en) 1999-11-16
WO1992001717A1 (en) 1992-02-06
EP0494294B1 (en) 1994-10-12
DE69104602D1 (de) 1994-11-17
ATE112783T1 (de) 1994-10-15
EP0494294A1 (en) 1992-07-15
US6040148A (en) 2000-03-21
GB9016315D0 (en) 1990-09-12
ES2062809T3 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
DK0494294T3 (da) Bakterielle stressproteiner
Hong et al. Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3
HUP9702387A1 (hu) Neisseria meningitidis proteináz-K-rezisztens felszíni fehérjéje
DE3588254D1 (de) Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
DE69333802T8 (de) Äusseres membranprotein von haemophilus
ES2147560T3 (es) Epitopos de proteinas del estres.
KR910000183A (ko) 재조합 포자충증 백신
ZA965482B (en) Novel antigen.
DE69532605D1 (de) Peptidfragmente von mikrobiellen stressproteinen und daraus hergestellte pharmazeutische zusammensetzungen für die behandlung und vorbeugung von entzündungserkrankungen
ATE287963T1 (de) Pseudomonas exotoxin - myelin basisches protein chimäre proteine
Purven et al. Purification and identification of Haemophilus ducreyi cytotoxin by use of a neutralizing monoclonal antibody
Schleifer et al. The Immunochemistry of Peptidoglycan: Separation and Characterization of Antibodies to the Glycan and to the Peptide Subunit
ATE94880T1 (de) Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung.
FI953093A (fi) Menetelmiä, joilla voidaan havaita ja hoitaa yksilöitä, joilla on epänormaaleja soluja, jotka ekspressoivat HLA-A2/tyrosinaasi-peptidiantigeenejä
EA200100700A1 (ru) Гены и белки и их применение
Husebekk et al. Characterization of bovine amyloid proteins SAA and AA
SE9001105D0 (sv) New methods foer diagnosis of tuberculosis
Heyermann et al. The heterogeneity of bovine IgG2—V. Differences in the primary structure of bovine IgG2 allotypes
ATE422503T1 (de) Rekombinante polypeptide aus mycoplasma und impfstoffe
DE69521985T2 (de) Diagnose und behandlung von streptococus oder enterococus infektionen
Cavaillon et al. Mitogenicity of streptococcal extracellular products and antagonism with concanavalin A
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
WO1998001754A1 (en) Novel proteins within the type e botulinum neurotoxin complex
PT85248A (fr) Procede d:isolement d:un peptide presentant des proprietes antigeniques isole de la proteine 28kd de ?s.mansoni?,anticorps monoclonaux reconnaissant au moins un epitope dudit peptide et applications de celui-ci dans l:induction de la synthese d:anticorps neutralisants